GlassScriptPhysician profile
Kimberly A Workowski
NPI 1588676712
$53,059.06
in general payments reported to CMS, 2019-2025
7 companies · $1,350 in 2025
The $1,350 reported for 2025 was more than what 82% of Infectious Disease providers received nationally (typical 2025 total: $187).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,256 · 2020: $2,670 · 2021: $12K · 2022: $6,319 · 2023: $6,699 · 2024: $15K · 2025: $1,350.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $20K · Honoraria: $1,608 · Travel and Lodging: $902 · Food and Beverage: $401.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $20,408.06 |
| Honoraria | $1,608.00 |
| Travel and Lodging | $901.61 |
| Food and Beverage | $400.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $23,517.18 | 2020-2024 | |
| Janssen Scientific Affairs, LLC | $13,301.08 | 2019-2023 | Symtuza |
| Viiv Healthcare Company | $7,749.10 | 2019-2022 | |
| Gilead Sciences, INC. | $6,722.50 | 2021-2025 | |
| La Jolla Pharmaceutical Company | $1,769.20 | 2024 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kimberly Workowski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.